Brighton Loveday
Adult Health · Provo, UTNPI 1871865071
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.
Across 77 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$251
- Pfizer$211
- AbbVie$157
- Johnson & Johnson$154
- Array Biopharma Inc$91
- Merck$87
- plus $732 from 22 others
What the payments were for
- Food & beverage$1,683100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $251 |
| Pfizer | 15 | $211 |
| AbbVie | 7 | $157 |
| Johnson & Johnson | 8 | $154 |
| Array Biopharma Inc | 5 | $91 |
| Merck | 3 | $87 |
| Bayer | 3 | $79 |
| Novartis | 4 | $78 |
| Puma Biotechnology, Inc. | 4 | $71 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Tersera Therapeutics LLC | 2 | $52 |
| Eisai Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Fennec Pharmaceuticals, Inc. | 1 | $30 |
| Pharmaessentia USA Corporation | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Geron Corporation | 1 | $24 |
| Menarini Silicon Biosystems, Inc. | 1 | $23 |
| Beone Medicines USA, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Tempus AI, Inc | 1 | $19 |
| Syndax Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Coherus Oncology, Inc. | 1 | $16 |
| Novocure Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DATROWAY$134
How this compares
$1,683 in reported general payments places this provider in the 80th percentile of 53 adult health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Provo
- Stephanie EllisProvo$997
- Darcy TrotterProvo$214
- Kraig PackerProvo$162
- Amber MarshProvo$141
- Maria BlackProvo$47
- Kelleen BrownProvo$33
- Kristin LarsonSalt Lake City$75K
- Tomeika Ulett-GarciaAmerican Fork$9K
- Lucinda RossSalt Lake City$4K
- Deborah BartonSaint George$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.